Allylamine cardiovascular toxicity

Harwood, 1963, Amines (lower aliphatic), Vol. 2, 123 Sutton, 1963, Aliphatic and Alicyclic Amines, Vol. 2, 2038 Lalich, 1969, Coronary artery hyalinosis in rats fed allylamine, Exp. Mol. Phatol., 10, 14, 10.1016/0014-4800(69)90045-8 Boor, 1979, Allylamine Cardiotoxicity: I. Sequence of Pathologic Events, Toxicol. Appl. Pharmacol., 50, 581, 10.1016/0041-008X(79)90413-7 Simpson, 1982, Coronary and thyroid arteriopathy-induced by allylamine and β-amino-propionitrile, Exp. Mol. Pathol., 37, 382, 10.1016/0014-4800(82)90050-8 Waters, 1948, Changes in the coronary arteroes of the dog following injections of allylamine, Am. Heart J., 35, 212, 10.1016/0002-8703(48)90101-X J.A. Will, Allylamine-Induced Cardiovascular Changes in Calves (Ph.D. Thesis), University Microfilms, Inc., Ann Arbor, MI. Fiume, 1962, Inhibition by aminoacetonitrile of allylamine-induced lesions in the rat's liver, J. Pathol. Bacteriol., 84, 256, 10.1002/path.1700840137 Eppinger, 1934, Uber Seröse entzundung, Klin. Wochensch., 13, 1105, 10.1007/BF01778446 1977, 29 1980, Vol. 1 1985, 914 Schuster, 1985, The interaction of representative members from two classes of antimycotics — the anzoles and the allylamines — with cytochrome P-450, Xenobiotica, 15, 529, 10.3109/00498258509045027 Shadomy, 1985, In vitro studies with SF-86-327, a new orally active alkylamine derivative, Sabouraudia, 23, 125, 10.1080/00362178585380201 Tsou, 1967, Synthesis of possible cancer chemotherapeutic agents based on enzyme rationale VI — allylamine derivatives, J. Pharm. Sci., 56, 484, 10.1002/jps.2600560412 Lyles, 1985, An allylamine derivative (MOL 72145) with potent irreversible inhibitory actions on rat aorta semicarbazide-sensitive amine oxidase, J. Pharm. Pharmacol., 37, 329, 10.1111/j.2042-7158.1985.tb05075.x A.E. Schweitzer, R.L. Fowlkes, J.H. McMakin and T.E. Whyte, Jr., Amines — Lower aliphatic amines in Kirk-Othmer Encyclopedia of Chemical Technology, 3rd Edn., Vol. 2, Wiley-Interscience, New York, pp. 272–283. 1979, 207 Hart, 1939, The toxicity of certain allylamines, Univ. Calif. Publ. Pharmacol., 1, 213 Hine, 1960, The toxicity of allylamines, Arch. Environ. Health, 1, 343, 10.1080/00039896.1960.10662707 Fassett, 1963, Vol. II, 2053 1976 Shumkova, 1981, Determination of allylamine in meat, Dostizh. v Obl. Sry]'ya i Prowduktsii Myas. Pr-va, M., 33 Mochalov, 1981, Determination of 2-propen-1-amine in milk, Gigiena Pr-va Moloch. Produktov i Obrab. Stoch, Vod Predpriyatii Moloch Prom-sti, M, 9 Ilitchkina, 1983, The chemical basis for maximal admissible concentrations of allylamine in water of reservoirs, Gigiena I Sanitariia (Moskva), 0, 80 Slooff, 1983, Comparison of the susceptibility of 22 freshwater species to 15 chemical compound. I. (Sub)acute toxicity tests, Aquat. Toxicol., 4, 113, 10.1016/0166-445X(83)90049-8 DeZwat, 1983, The microtox® as an alternative assay in the acute toxicity assessment of water pollutants, Aquat. Toxicol., 4, 129, 10.1016/0166-445X(83)90050-4 Brauchli, 1928, Uber den Einfluss von Allygruppen auf die pharmakologische Wirkung verschiedener Amine, Amine. Arch. Exp. Pathol. Pharmakol., 129, 72, 10.1007/BF01863877 Carlier, 1911, Notes on the physiology of some of the allyl compounds, Br. Med. J. Pt., 2, 609 Carlier, 1912, Some further experiments on the physiology of the allyl compounds, Biochem. J., 6, 182, 10.1042/bj0060182 Piazza, 1915, Zur Kenntnis der Wirkung der Allylverbindungen, Zeitschr. Exp. Pathol. Ther., 17, 318, 10.1007/BF02656841 Mellon, 1935, Experimental necrotizing arteriolitis induced by a protein cleavage product, 33, 192 Hart, 1939, Comparative toxicity of certain allylamines, J. Pharmacol. Exp. Ther., 66, 18 Waters, 1955, The reaction of the artery wall to injury by chemicals or infection, 91 Waters, 1956, Studies on the pathogenesis of vascular disease. The effect of intravenous egg-yolk emulsions on inflammatory lesions of the aorta and coronary arteries of dogs, Yale J. Biol. Med., 29, 9 Waters, 1957, Studies on the pathogenesis of vascular disease. The effect of intravenously injected human plasma and of lipid-rich human plasma globulins on inflammatory lesions of the coronary arteries of dogs, Yale J. Biol. Med., 30, 57 Waters, 1962, Studies on the pathogenesis of vascular disease. The effect of a short-term, cholesterol-rich diet on inflammatory lesions of the coronary arteries of dogs, Yale J. Biol. Med., 35, 113 Donomae, 1957, Production of coronary heart disease in the habbit by lanolin feeding, Circ. Res., 5, 645, 10.1161/01.RES.5.6.645 Bloor, 1963, Experimental Coronary Arteriography. I. The distribution and extent of allylamine-induced vascular lesions in the dog, Radiology, 81, 770, 10.1148/81.5.770 Boor, 1985, Ultrastructural alterations in allylamine cardiovascular toxicity. Late Myocardial and Vascular Lesions, Am. J. Pathol., 121, 39 Lalich, 1972, Myocardial fibrosis and smooth muscle cell hyperplasia in coronary arteries of allylamine-fed rats, Am. J. Pathol., 66, 225 Lowman, 1966, The Experimental Production of Unilateral Renal Artery Injury and Hypertension. I. The arteriography of allylamine-induced renal vascular lesions in the dog, Radiology, 86, 1003, 10.1148/86.6.1003 Lowman, 1969, Experimental Production of Intracranial Vascular Lesions. Allylamine-induced vascular lesions of the brain and intracranial infraction, Acta. Radiol. Diagn. (Stockholm), 9, 383 Saito, 1976, Effect of coronary vasodilators on cardiac dynamics of the normal dog and the dog with experimental coronary sclerosis, Jpn. Circ. J., 40, 363, 10.1253/jcj.40.363 Saito, 1977, Effect of diltiazem on coronary blood flow of the heart with experimental coronary sclerosis and on regional myocardial blood flow of the heart with acute myocardial ischemia, Arzneim.-Forsch., 37, 1669 Will, 1971, A chemically-induced acute model of myocardial damage in intact calves, Res. Comm. Chem. Pathol. Pharmacol., 2, 61 Inouye, 1971, Vascular lesions in rhesus monkeys fed allylamine, 30, 293 Concard, 1956, Histochemical evaluation of canine coronary artery and aortic lesions induced by intravenous allylamine, Circ. Res., 4, 263, 10.1161/01.RES.4.3.263 Boor, 1982, Ultrastructural alterations in allylamine-induced cardiomyopathy, Early Lesions. Lab. Invest., 47, 76 Boor, 1980, Allylamine Cardiotoxicity, II. Histopathology and Histochemistry, Am. J. Pathol., 100, 739 Carlson, 1973, Coronary blood flow of unanesthetized dogs with experimental coronary artery disease, Cardiovas. Res., 7, 789, 10.1093/cvr/7.6.789 Saito, 1976, Effect of coronary vasodilators on cardiac dynamics of the normal dog and the with experimental coronary sclerosis, Jpn. Circ. J., 40, 363, 10.1253/jcj.40.363 Guzman, 1961, Myocarditis produced by allylamines, Arch. Environ. Health, 2, 62, 10.1080/00039896.1961.10662817 Lalich, 1974, Influence of hydralazine consumption on allylamine induced myocardial fibrosis and hypertrophy in rats, Exp. Mol. Pathol., 21, 29, 10.1016/0014-4800(74)90076-8 Boor, 1977, Allylamine-induced myocardial damage: protection by monoamine oxidase inhibitors, 36, 379 Abrams, 1971, Monoamine oxidase inhibitors: The pharmacology and place in hypertension, 331 Boor, 1980, Allylamine cardiotoxicity: III. Protection by semicarbazide and in vivo deragements of monoamine oxidase, Toxicology, 18, 87, 10.1016/0300-483X(80)90072-4 Boor, 1982, Biotransformation of the cardiovascular toxin, allylamine, by rat and human cardiovascular tissue, J. Mol. Cell Cardiol., 14, 679, 10.1016/0022-2828(82)90165-1 Nelson, 1982, Allylamine cardiotoxicity: IV. Metabolism to acrolein by cardiovascular tissues, Biochem. Pharmacol., 31, 509, 10.1016/0006-2952(82)90152-6 Rucker, 1972, Properties of rabbit aorta amine oxidase, 139, 286 Lyles, 1985, Vascular smooth muscle: a major source of the semicarbizide-sensitive amine oxidase of the rat aorta, J. Pharm. Pharmacol., 37, 637, 10.1111/j.2042-7158.1985.tb05100.x Lewinsohn, 1978, A benzylamine oxidase distinct from monoamine oxidase B — widespread distribution in man and rat, Biochem. Pharmacol., 27, 1857, 10.1016/0006-2952(78)90033-3 Boor, 1985, Allylamine cardiovascular toxicity: V. Tissue distribution and toxicokinetics after oral administration, Toxicology, 35, 167, 10.1016/0300-483X(85)90013-7 Hysmith, 1985, Allylamine cardiovascular toxicity: VI. Subcellualr distribution in rat aortas, Toxicology, 35, 179, 10.1016/0300-483X(85)90014-9 Lyles, 1984, The interaction of semicarbazide-sensitive amine oxidase with MAO inhibitors, 547 Valiev, 1968, Influence exerted by some aliphatic amines on the monoamine oxidase system in rats, Farmakol. I. Toksikol. (Moscow), 31, 238 Valiev, 1974, Metabolism of biogenic amines during alkylamine poisoning, Voprosy. Biokhim, i. Immunol. Chel. i Zhivotn, 33 Rando, 1977, The pseudoirreversible inhibition of monoamine oxidase by allylamine, Mol. Pharmacol., 13, 1005 Silverman, 1985, Inactivation of monoamine oxidase by allylamine does not result in flavin attachment, J. Biol. Chem., 260, 14648, 10.1016/S0021-9258(17)38619-2 Hysmith, 1986, Comparative toxicity of the cardiovascular toxin allylamine to porcine aortic smooth muscle and endothetial cells, Toxicology, 39, 141, 10.1016/0300-483X(86)90115-0 Grossman, 1986, Prevention of allylamine-induced vascular cell injury by benzylamine oxidase inhibitors, The Toxicologist, 6, 201